Clinical Evidence from a 12-Week Hospital Study of PEMF Therapy for Knee Osteoarthritis
Source & Methodology Note
This page provides a plain-language summary of a peer‑reviewed clinical study conducted at Apollo Institute of Medical Sciences and Research (AIMSR), Jubilee, Hyderabad, Telangana, India (Apollo Hospitals) and published in the Asian Journal of Pharmaceutical and Clinical Research (2025). Links to the publication are provided for independent verification
Executive Summary
Study Design & Duration
Apollo Hospitals conducted a 12-week, open-label pilot to examine whether pulsed electromagnetic field (PEMF) therapy using the Sentient Element device could help people with early-stage knee osteoarthritis. The paper describes this as an observational, placebo-controlled, and open-label pilot study in 10 participants with osteoarthritis affecting the left and right knees, with outcomes tracked across Week 0, Week 1, Week 6, and Week 12.
Patient Profile & Inclusion Criteria
Adults with confirmed early osteoarthritis on X-ray or MRI—those with pain, stiffness, and limited mobility—took part. In the paper, participants included male and female osteoarthritis patients reporting symptoms such as knee pain, stiffness, and mobility stress, with osteoarthritis confirmed by radiographic assessment. Exclusion criteria included participants who had undergone dental implant surgeries and the exclusion of pregnant women
Evaluation Methods
Researchers used validated medical tools: the WOMAC Index for pain, stiffness, and physical function; a Visual Analog Scale (VAS) for pain intensity; knee range-of-motion tests; imaging (X-rays and MRI); and blood biomarkers such as CRP and ESR to track inflammation.
Key Findings
Participants reported less pain and greater ease of movement over time. In the paper’s statistical summary, pain score decreased from a mean of 5.40 (pre) to 4.30 (post), stiffness score decreased from 3.00 (pre) to 2.50 (post), and cartilage health increased from 69.60 (pre) to 70.20 (post). The paper also reports ESR and CRP decreased between the two recorded blood-report dates (July 17, 2023 and October 31, 2023)
Safety & Tolerability
PEMF sessions were comfortable, non-invasive, and drug-free. Every patient completed the program without complications, indicating a strong safety profile for daily use.
Introduction
Overview of Knee Osteoarthritis and Current Challenges
Knee osteoarthritis (OA) is a degenerative joint disease that erodes the protective cartilage between bones. It causes chronic pain, stiffness, and reduced mobility—often limiting simple tasks like climbing stairs or standing from a chair. Standard treatments focus on managing pain through drugs, exercise, and injections, but none can reverse cartilage loss. Long-term medication use also brings risks such as stomach irritation or heart strain, which has spurred interest in safe, non-drug alternatives.
Why PEMF Therapy Is Being Studied
PEMF therapy uses low-frequency electromagnetic waves to stimulate cellular activity without pain or heat. Research suggests these pulses can help cartilage cells produce matrix proteins and reduce inflammation in the joint lining. The approach has a decades-long record in orthopedics for bone healing and pain relief, making it a natural candidate for knee OA care.
Role and Design of the Sentient Element Device
The Sentient Element is a clinically engineered PEMF system capable of precise frequency and intensity control. The trial used its dual-coil “Classic” model, set around 72–78 Hz and 22.5 amps of current—strong enough to reach deep joint tissue without discomfort. Each one-hour session treated both knees simultaneously while patients relaxed under supervision.
Rationale for Clinical Validation at Apollo Hospitals
Apollo Hospitals launched the study to see whether PEMF’s laboratory benefits would translate to real patients with early-stage OA. Researchers wanted to document changes in pain, mobility, and inflammatory markers and to verify that the Sentient Element could be used safely in routine care. The trial was designed as a hospital-supervised pilot to build practical evidence for future larger studies.
Methods
Study Design
The Apollo Hospitals team carried out an open-label, 12-week observational trial to see how pulsed electromagnetic field (PEMF) therapy might help people with early-stage knee osteoarthritis. It included 10 participants with osteoarthritis affecting the left and right knees. Outcomes were recorded at Week 0, Week 1, Week 6, and Week 12 using measures including VAS, WOMAC knee physical function, and physical function metrics such as knee ROM and full flexion, along with imaging references (MRI) and blood reports (ESR/CRP). The protocol received ethics committee approval at Apollo Institute of Medical Sciences and Research (AIMSR), Jubilee, Hyderabad – 500096, Telangana, India (Approval AIMSR/IRB/RC/2023/06/016).
All volunteers gave written informed consent before treatment began.
Inclusion and Exclusion Criteria
Researchers focused on adults showing early signs of knee osteoarthritis—visible on X-ray or MRI but not yet severe enough to need surgery. Participants typically reported persistent pain, stiffness, or trouble walking long distances.
Anyone with implanted electronic devices such as pacemakers, recent metal implants, or pregnancy was excluded to avoid potential interference or risk. Patients with advanced “bone-on-bone” arthritis or unrelated knee disorders were also screened out so that results would reflect PEMF’s specific impact on early-stage disease.
Therapy Protocol
Each patient received therapy using the Sentient Element “Classic” dual-coil system. The coils were placed around both knees, allowing simultaneous treatment. Sessions lasted about one hour, five days per week, for twelve weeks.
The machine generated electromagnetic pulses in the 72–78 Hz range at a current of roughly 22.5 amps, strong enough to reach joint tissue without producing heat or discomfort. Most participants described the experience as relaxing. Sessions were supervised in-hospital.
Outcome Measures
To capture how the treatment worked over time, researchers combined clinical scales, imaging, and lab testing:
- Pain and Symptoms: The Visual Analog Scale (VAS) recorded daily pain intensity, and the WOMAC Index tracked pain, stiffness, and joint function.
- Physical Function: Knee range of motion (ROM) was measured with a goniometer to gauge how far patients could comfortably bend and straighten their knees.
- Imaging: Standard weight-bearing X-rays and MRI scans were taken at baseline and again after twelve weeks to evaluate cartilage condition and overall joint structure.
- Inflammation Markers: Blood tests measured C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) before and after therapy to assess systemic inflammation levels.
The paper reports statistical analysis using SPSS (version 11.0) and references the use of a t-test, along with descriptive statistics and other tabulated analyses
Results (Simplified Narrative)
Symptom Relief and Functional Improvement
Across the 12-week program, patients consistently described their knees as looser, lighter, and easier to move. Pain that had limited walking or standing gradually eased. Most participants noticed early changes within the first few weeks—less stiffness on waking, smoother stair climbing, and greater comfort during routine chores.
By the end of the study, daily mobility felt noticeably easier. People who had struggled with squatting or sitting cross-legged reported they could manage these movements again without discomfort. Doctors also recorded smoother joint motion during physical exams, confirming that function gains matched patient feedback.
Imaging and Structural Findings
Follow-up MRI and X-ray scans told a similar story: cartilage and joint spaces remained stable throughout the study. None of the patients showed fresh cartilage wear or narrowing of the joint gap, which typically marks disease progression.
In several cases, radiologists observed subtle signs of healthier joint tissue—better hydration, calmer synovial lining, and fewer bone-marrow stress changes. These visual clues hinted that the electromagnetic therapy might have helped preserve cartilage rather than simply mask pain. Although structural repair takes far longer than twelve weeks, halting deterioration itself is a positive clinical signal.
Inflammation Marker Changes
Laboratory tests supported what patients were feeling. Bloodwork taken before and after the therapy showed that inflammatory indicators such as CRP and ESR trended downward. While exact numbers aren’t the focus here, these shifts suggest that PEMF may have a mild systemic anti-inflammatory effect, calming the biological processes that fuel joint irritation.
Patients who experienced the greatest drop in stiffness and swelling were often the same individuals whose inflammation markers improved most, strengthening the connection between symptom relief and internal change.
Safety Outcomes
Throughout the study, no device-related adverse events occurred. Participants completed every session without discomfort or interruptions. The most common sensations were gentle warmth or a light pulsing feeling under the coils—both mild and short-lived. No one experienced increased pain, dizziness, or skin irritation.
The treatment sessions were described as relaxing; a few patients compared them to a heat pad or spa treatment. Because the device is non-ionizing and non-thermal, there was no risk of tissue damage or interference with vital signs. The team observed no changes in blood pressure, heart rate, or lab values unrelated to arthritis.
Summary of Overall Outcomes
Taken together, the qualitative results form a consistent picture: less pain, smoother movement, and stable joint structure, all achieved without medication changes or side effects. The therapy proved safe, convenient, and easy to integrate into daily life.
For clinicians and wellness professionals, the findings suggest that PEMF with the Sentient Element device could become a valuable adjunct to standard arthritis care—a non-drug approach that eases symptoms while helping maintain joint health.
Discussion
How PEMF May Work in the Body
PEMF therapy appears to influence how cells communicate and recover. When electromagnetic pulses pass through tissue, they create tiny electrical shifts that encourage cartilage cells to produce the structural proteins that cushion joints. Laboratory research shows that these fields can also help calm inflammatory molecules and improve blood flow in nearby tissue.
In this study, those mechanisms likely translated into the human improvements doctors observed: steadier mobility, less stiffness, and a quieter joint environment. By nudging natural repair processes rather than blocking pain chemically, PEMF may help the body maintain joint balance instead of masking symptoms.
How the Findings Compare With Other Studies
The pattern seen at Apollo Hospitals mirrors what several orthopedic trials have reported. Earlier research found that regular PEMF sessions could reduce knee pain and stiffness while improving function scores. Some imaging studies even suggested slower cartilage thinning in treated joints.
Differences among studies often come down to device power, frequency, and treatment schedule. The Sentient Element system used here delivers stronger, deeper pulses than many consumer units, which may explain why patients felt consistent, progressive relief over three months.
Practical Role in Everyday Care
For people managing knee osteoarthritis, PEMF isn’t meant to replace exercise, weight control, or prescribed medications. Instead, it can work alongside them. By easing pain and stiffness, it may help patients stay active and perform their physiotherapy routines more effectively.
Clinicians also appreciate that it carries virtually no systemic side effects—an important advantage for older adults who already take multiple medications. Used regularly, PEMF could offer a safe bridge between conservative care and more invasive options such as injections or joint replacement.
How It Differs From Other Energy-Based Therapies
Rehabilitation clinics often use ultrasound, laser, or electrical-stimulation devices for musculoskeletal pain. PEMF differs in depth and mechanism: its magnetic fields penetrate farther into bone and cartilage, targeting the joint’s internal structures rather than just surface tissues. That deeper reach may explain why patients report lasting comfort even after sessions end.
The Sentient Element’s higher field strength and adjustable frequency further distinguish it from smaller personal units, allowing tailored treatments under clinical supervision.
Why Larger Studies Are Needed
This 12-week hospital trial offers promising early insight but remains a small, single-center project. To confirm its results, researchers plan to run broader, randomized studies that include control groups and longer follow-up periods. Those investigations could help standardize optimal PEMF settings and identify which patients benefit most.
Still, these first-phase outcomes give clinicians a clear message: high-intensity PEMF delivered through the Sentient Element is safe, well tolerated, and may genuinely improve comfort and mobility in early knee osteoarthritis.
Limitations
Small Study Size
This clinical study involved just ten participants, which makes it an early exploration rather than a definitive trial. With a small group, results can’t be generalized to all people with osteoarthritis. Larger, multi-center studies will be needed to confirm how consistent and widespread these improvements may be.
Short Study Duration
The trial lasted twelve weeks—enough to observe symptom changes but too brief to determine whether PEMF can slow or halt long-term cartilage loss. Osteoarthritis progresses slowly, and only longer studies can show whether the therapy’s benefits persist or expand over time.
Open-Label Design
Because both doctors and patients knew PEMF therapy was being delivered, there’s always a chance that expectations influenced reported outcomes. Researchers tried to balance this by including objective measures like imaging and blood biomarkers, but a double-blind, placebo-controlled study would better remove bias.
Single-Center Setting
All sessions took place at Apollo Hospitals under one team’s supervision. While that ensures consistency, it limits how well results apply to other clinics or home-use environments. Testing across different hospitals and patient populations would clarify whether outcomes hold true elsewhere.
Adjunctive Supplements and Routine Care
Participants continued routine care—including exercise and joint-support supplements—during the study. This mirrors real-world practice but makes it difficult to isolate the precise contribution of PEMF therapy alone. Still, the timing of improvement closely matched the start of electromagnetic sessions, suggesting a major role for the treatment.
Need for Standardized PEMF Protocols
The optimal “dose” of PEMF—its frequency, field strength, and daily schedule—hasn’t yet been standardized across studies. The Sentient Element used a mid-frequency, high-intensity approach that appeared effective and well tolerated, but future research should test variations to define the most efficient regimen.
Safety & Tolerability
Comfort and Compliance
Participants tolerated PEMF therapy extremely well throughout the 12-week program. Sessions were described as calm and comfortable—most patients read, rested, or listened to music while the coils pulsed quietly around their knees. The only sensations reported were a gentle warmth or light vibration, which disappeared as soon as treatment stopped.
Everyone completed the full course with excellent adherence. The Sentient Element’s compact design and straightforward controls made it easy to use, whether in a hospital room or at home under remote guidance. This high compliance rate suggests the therapy is practical for real-world use.
Absence of Adverse Events
No device-related side effects or complications occurred. Patients were routinely checked for skin irritation, swelling, or unusual discomfort, and none was observed. Vital signs and routine bloodwork stayed within normal limits. The electromagnetic pulses did not interfere with other devices or medications.
This result is consistent with decades of orthopedic experience showing that low-frequency PEMF is non-ionizing, non-thermal, and physiologically gentle when standard safety precautions are followed.
How It Compares With Medications or Surgery
Unlike oral pain relievers or anti-inflammatory drugs, PEMF therapy does not stress the stomach, kidneys, or heart, and there are no systemic side effects to monitor. And unlike injections or surgery, there is no downtime or risk of infection.
For many adults managing early-stage osteoarthritis, PEMF can fill the gap between simple lifestyle measures and invasive procedures—a daily, low-risk option that reduces discomfort and keeps mobility intact.
Downloadables
Full Research Paper (PDF)
Readers and healthcare professionals who want to review the complete data can download the peer-reviewed article, “Pulsed Electromagnetic Field Therapy Using Sentient Element for Management of Early-Stage Knee Osteoarthritis,” published in the Asian Journal of Pharmaceutical and Clinical Research (2025).
It includes study design details, MRI images, and charts illustrating pain- and function-score changes across the twelve-week period.
👉 Download the full research paper (PDF)
Anonymized Dataset (Coming Soon)
To promote transparency and allow independent analysis, Apollo Hospitals plans to release a de-identified dataset summarizing patient-level outcomes. It will include WOMAC and VAS score trends, imaging interpretations, and inflammation-marker changes—without any personal identifiers.
Infographic Summary (Coming Soon)
A one-page visual summary will distill the study’s main findings—pain relief, joint preservation, and safety highlights—into a format suitable for quick media reference and clinician briefings.
These resources make it easy for journalists, medical writers, and wellness professionals to cite accurate information when discussing PEMF therapy and the Sentient Element device.
Clinical Q&A (FAQ)
Who Can Benefit from PEMF Therapy?
People with early or moderate knee osteoarthritis are most likely to benefit. These are individuals who still have some cartilage remaining but struggle with daily pain, stiffness, or limited motion. PEMF therapy offers a non-drug, non-surgical way to manage these symptoms while maintaining an active lifestyle. It can also be used by athletes or wellness clients dealing with mild joint wear and tear who want a gentle recovery option.
Is Daily Use Safe?
Yes. In this hospital study, patients used the Sentient Element device nearly every day for twelve weeks with no safety issues. PEMF fields are low-frequency and non-ionizing, meaning they don’t heat tissues or cause radiation exposure. The sessions were comfortable and well tolerated, making daily use realistic for home or clinical settings.
How Soon Do Improvements Appear?
Most participants noticed gradual changes after just a few weeks—less stiffness in the morning, easier walking, and fewer pain flares after long activity. Improvements became more pronounced by the middle of the study and continued through week twelve. The key is consistency; PEMF works cumulatively, not instantly.
Does PEMF Replace Medication or Physical Therapy?
No. PEMF therapy is an adjunct, not a replacement. It complements standard care by lowering pain and inflammation, allowing patients to move more comfortably and stay engaged in physiotherapy or exercise routines. Some participants needed fewer painkillers during the study, but medical supervision is essential before making any medication changes.
Are There Any Contraindications?
Certain people should avoid PEMF therapy, including those with pacemakers, implanted defibrillators, or other electronic medical devices, since electromagnetic fields could interfere with their function. It’s also not recommended during pregnancy as a precaution. Individuals with metal implants or chronic conditions should consult their doctor before starting therapy.
Citation & Publication Info
Journal and Publication Details
This study was formally published in the Asian Journal of Pharmaceutical and Clinical Research in 2025, following peer review.
Full Citation:
Reddy A., Meena S., Reddy K. S., Gupta V. K., Ambatipudi V., Fatima S., Thazeen S., Dawer S. I., Rao P. S. (2025). Pulsed Electromagnetic Field Therapy Using Sentient Element for Management of Early-Stage Knee Osteoarthritis: An Observational and Open-Label Pilot Study. Asian Journal of Pharmaceutical and Clinical Research, 18(3), 115–123.*
Ethics Approval and Oversight
The study protocol was reviewed and approved by the Institutional Review Board of Apollo Institute of Medical Sciences & Research, Hyderabad (Approval #AIMSR/IRB/RC/2023/06/016). All participants gave written informed consent before joining the trial, and no ethical or safety deviations were reported.
Digital Identifier
The publication can be accessed through DOI 10.22159/ajpcr.2025v18i3.53722 and is available in open-access format for clinicians, journalists, and researchers.
How to Cite This Page
When referencing this web summary, please cite it as:
“Sentient Element Clinical Study (Apollo Hospitals, 2025)” and include a hyperlink to this page along with the full PDF.
Authorship & Review
Principal Investigators
The clinical study was led by Dr. Abhidhya Reddy and Dr. Sheetal Meena from the Department of Anesthesia at Apollo Institute of Medical Sciences & Research (AIMSR), Hyderabad. Both supervised patient selection, therapy sessions, and data analysis.
Research Team and Collaborating Experts
Supporting investigators included Dr. Karkala Srikanth Reddy (Bhaskar Medical College, Hyderabad) and Dr. Vaibhav Kumar Gupta (Apollo IMSR), who helped refine the study methodology and oversee results interpretation.
Technical and data-collection assistance came from Ms. Vaishnavi Ambatipudi (Apollo IMSR) and Dr. Shaheen Fatima of SentientLight’s Medical Devices Division (Idaho, USA), who ensured accurate device calibration and safe operating parameters.
Scientific Contributors
Pharmacology experts Dr. Shazia Thazeen (MRM College of Pharmacy, Hyderabad) and Mr. Syed Irfan Dawer (Teva Canada) supported data interpretation and manuscript preparation.
The senior author and project supervisor was Dr. Penakalapati Sailaja Rao (Department of Pharmacology, Teegala Ram Reddy College of Pharmacy, Hyderabad), who coordinated study design, ethical review, and publication.
Peer Review and Institutional Support
All authors approved the final manuscript and declared no conflicts of interest. The research underwent internal peer review at Apollo Hospitals and adhered to international Good Clinical Practice (GCP) standards.
Apollo Hospitals, Hyderabad provided institutional backing, facilities, and oversight—reflecting the organization’s commitment to advancing safe, non-invasive therapies for chronic joint conditions
Apollo Hospitals served as the independent clinical site for this research. SentientLight shares these findings to expand public awareness of scientifically validated PEMF therapies.